BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 18172277)

  • 1. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
    Korsisaari N; Ross J; Wu X; Kowanetz M; Pal N; Hall L; Eastham-Anderson J; Forrest WF; Van Bruggen N; Peale FV; Ferrara N
    Clin Cancer Res; 2008 Jan; 14(1):249-58. PubMed ID: 18172277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
    Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
    Luque GM; Perez-Millán MI; Ornstein AM; Cristina C; Becu-Villalobos D
    J Pharmacol Exp Ther; 2011 Jun; 337(3):766-74. PubMed ID: 21406548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
    Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
    Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
    Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
    Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of VEGF-C/VEGFR-3 system and lymphatic vessel extent in normal and adenomatous human pituitary tissues.
    Onofri C; Losa M; Uhl E; Stalla GK; Renner U
    Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):152-7. PubMed ID: 18205092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressive level of vascular endothelial growth factor in peripheral blood in patients with pituitary adenomas].
    Kong YG; Ren ZY; Su CB; Wang RZ; Xing B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):164-7. PubMed ID: 15171554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro.
    Ławnicka H; Pisarek H; Kunert-Radek J; Pawlikowski M
    Neuro Endocrinol Lett; 2008 Feb; 29(1):113-6. PubMed ID: 18283262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model.
    Verheul HM; Hammers H; van Erp K; Wei Y; Sanni T; Salumbides B; Qian DZ; Yancopoulos GD; Pili R
    Clin Cancer Res; 2007 Jul; 13(14):4201-8. PubMed ID: 17634549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min mice.
    Korsisaari N; Kasman IM; Forrest WF; Pal N; Bai W; Fuh G; Peale FV; Smits R; Ferrara N
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10625-30. PubMed ID: 17553957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotent tumor cells in benign pituitary adenomas associated with multiple endocrine neoplasia type 1.
    Weil RJ; Huang S; Pack S; Vortmeyer AO; Tsokos M; Lubensky IA; Oldfield EH; Zhuang Z
    Cancer Res; 1998 Oct; 58(20):4715-20. PubMed ID: 9788627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple endocrine neoplasia type 1-associated cystic pancreatic endocrine neoplasia and multifocal cholesterol granulomas.
    Kimura N; Komuro K; Uchino S; Yagihashi S; Ishidate T; Ishizaka M
    Pathol Int; 2010 Apr; 60(4):321-5. PubMed ID: 20403035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
    Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
    Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis and pituitary tumors.
    Cohen AB; Lessell S
    Semin Ophthalmol; 2009; 24(3):185-9. PubMed ID: 19437356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.
    Onofri C; Theodoropoulou M; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U
    J Endocrinol; 2006 Oct; 191(1):249-61. PubMed ID: 17065408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
    Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
    Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in pituitary adenomas.
    Yamada S; Takada K
    Microsc Res Tech; 2003 Feb; 60(2):236-43. PubMed ID: 12539178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
    Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
    Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.